Možnosti využití silymarinu v léčbě diabetu se zaměřením na gestační diabetes
| Title in English | Possibilities of using silymarin in the treatment of diabetes with a focus on gestational diabetes mellitus |
|---|---|
| Authors | |
| Year of publication | 2025 |
| Type | Article in Periodical |
| Magazine / Source | Diabetes Metabolismus Endkrinologie Výživa |
| MU Faculty or unit | |
| Citation | |
| web | https://www.tigis.cz/images/stories/DMEV/2025/03/DMEV_3_25_Bartakova.pdf |
| Keywords | diabetes mellitus; gestational diabetes; silymarin; metabolism |
| Attached files | |
| Description | Silymarin is one of the most frequently used and oldest therapeutic agents for liver diseases. Due to its significant antioxidant and antidiabetic properties, it is widely used in the treatment of various liver and metabolic diseases, as well as in certain intoxications. Silymarin is a complex mixture of flavolignans, derived from the milk thistle plant (Silybum marianum), with silibin being the most important component. The current review summarizes available data on the potential use of silymarin as an adjuvant treatment for diabetes mellitus, including gestational diabetes. |
| Related projects: |